InMed Pharmaceuticals Inc. (INM)
Market Closed
15 Oct, 08:00 PM
$
1. 33
+0.02
+1.5267%
Pre Market
$
+0.13 +9.7744% 1. 46
7.47M Market Cap
- P/E Ratio
- Div Yield
17,533 Volume
0 Eps
$ 1.31
Previous Close Investors:
Want to track INM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
InMed Pharmaceuticals Inc. (INM) Statistics
Valuation metrics
Market Cap 7.47M
Enterprise value 5.28M
Trailing P/E (ttm) -0.39
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 0
Price/Book (mrq) 5.53
Enterprise Value/Revenue 0
Enterprise Value/EBITDA -0.54
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 58.25K
Average volume (90 days) 3.01M
Price summary
52-Week low 0.57
52-Week high 2.33
Beta -
50-Day moving average 1.36
200-Day moving average 1.05
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -34.37
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 15 Nov 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.01%
Operating margin -0.01%
Operational effectiveness
Return on assets -4.15%
Return on equity -1.35%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 471.05
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.87
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.51
Total debt (mrq) -
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 1.37%
Book value per share (mrq) 0.25
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
